Abingdon Health PLC (GB:ABDX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Abingdon Health PLC has partnered with Salignostics and Crest Medical to launch the world’s first saliva-based pregnancy self-test under the Boots brand in the UK. The innovative test will be available both in-store and online, marking a significant entry into the booming self-test market, which is projected to grow substantially. This strategic move demonstrates Abingdon Health’s commitment to expanding its product portfolio and strengthening its retail partnerships.
For further insights into GB:ABDX stock, check out TipRanks’ Stock Analysis page.